Liaoning Cheng Da Is Expected To Become The First A Share To Spin Off To GEM Listed Companies.

Golden Rooster lays golden eggs and golden eggs hatch new chickens.

This game, who does not love the capital market? Yesterday, Liaoning Cheng Da announced that the board of directors passed the motion on the launching of the spin off and listing of the Liaoning subsidiary of the Liaoning subsidiary of the company's holding subsidiary.

This means that after the SFC indicated that allowing domestic listed companies to spin off their subsidiaries to the gem, A shares had a substantive move to the gem listing, and Liaoning Cheng Da is expected to become the first company to eat crab.

　　成大生物上市增厚遼寧成大價值

Liaoning's announcement by Cheng Da said that the company intends to spin off big organisms into the Shenzhen stock exchange's gem, which will be divided into a large biological chip, and will start listing guidance in the near future.

Affected by the announcement, yesterday, Liaoning opened a big 7% in early morning, leading to the collective price rise of the split share price of the same party.

However, the shock of the late fall was only 1.10% higher.

Prior to this, Guotai Junan analyst Liang Jing and Dong Le pointed out in the Liaoning research report that the big biological listing will increase the value of Liaoning from two aspects of performance growth and valuation enhancement.

According to the valuation level of gem at present, the market value of large biological holdings reached 15 billion yuan, which is expected to rise by nearly 100%.

Yesterday, after the announcement of the split announcement, Guotai Junan issued another research report, which has increased the share of the issue of large biological products in 2010 to 71% in April.

It is predicted that this year's sales of large organisms will reach 7 million to 8 million people, and net profit will reach 500 million yuan, up 125% over the same period.

According to the valuation level of the current biological vaccine company, it is expected that the market value of the large biological holding company will reach more than 10 billion yuan, and the net assets will be increased by about 10 yuan per share.

According to the analysis of the industry, there is no policy hindrance to Liaoning's splitting up.

Guotai Junan believes that the successful spin off of giant organisms on the gem will significantly improve Liaoning's ability to make most of its profits.

Take 2009 as an example, GF Securities contributed 1 billion 220 million yuan in profits, accounting for more than 91%.

And if it is expected to make a profit of 400 million yuan for large organisms, it is expected to contribute more than 25% of the profits to Liaoning's largest industry, thereby weakening the impact of the ups and downs of the coupon's business performance on Liaoning's growth.

　　機構逆市熱推分拆概念股

In April 13th, when the CSRC allowed the listing of domestic listed companies to spin off their subsidiaries to the gem, the announcement became the focus of attention of all parties.

At present, the GEM listed companies generally have a huge valuation premium. Once a large number of high-quality enterprise shares owned by the main board listed companies have been allocated to spin off, no matter whether the subsidiary companies or the parent companies have a huge increase in valuation.

As a result, after the announcement of the stock market, the stock market was sluggish, and the brokers issued a research report, touting the related stocks and listing various "beneficial stocks" list.

In addition to Liaoning Cheng Da, Tongfang shares have been listed as the "chief Hua Dan" by the securities companies.

Guotai Junan analysis, because the same shares rely on Colleges and universities, with a high level of technology, a large number of projects and subsidiaries, the future separation of huge imagination.

CIC also pointed out that many subsidiaries of Tongfang stock accord with the conditions of splitting and listing, and the company is expected to be listed through a spin off step by step. Once the subsidiary is listed, the same party will get huge investment returns.

In addition, CITIC Guoan, Bo Yun new material, mountain river intelligence, Changchun high and new technology, Huagang technology, Bo Rui communication, Cheng Zhi shares, Fosun medicine, comprehensive arts shares, purple light shares are also the hot spots of the institutional circle.